Catherinet Doherty News Today

StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a report issued on Friday. DGX has been the topic of several other reports. Citigroup upped their price target on Quest Diagnostics from $135.00 to $145.00 and gave the company a neutral rating in a research […]

Philadelphia Trust Co. reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 17.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,329 shares of the medical research company’s stock after selling 945 shares during the period. Philadelphia Trust Co.’s […]

StockNews.com cut shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a research report released on Friday morning. DGX has been the subject of a number of other research reports. Barclays lifted their price target on shares of Quest Diagnostics from $138.00 to $144.00 and gave the […]

Quest Diagnostics (NYSE:DGX – Free Report) had its target price upped by Citigroup from $135.00 to $145.00 in a report released on Wednesday, Benzinga reports. The firm currently has a neutral rating on the medical research company’s stock. Other research analysts have also recently issued research reports about the stock. SVB Leerink initiated coverage on […]

Yousif Capital Management LLC decreased its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 4.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,102 shares of the medical research company’s stock after selling 1,236 shares during the […]

Motley Fool Asset Management LLC trimmed its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 9.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,822 shares of the medical research company’s stock after selling 189 shares during the quarter. […]

Quest Diagnostics (NYSE:DGX – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 8.720-8.970 for the period, compared to the consensus EPS estimate of 8.750. The company issued revenue guidance of $9.4 billion-$9.5 billion, compared to the consensus revenue estimate of $9.4 billion. […]

Cwm LLC increased its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,200 shares of the medical research company’s stock after purchasing an additional 232 shares during the period. […]

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price boosted by investment analysts at Citigroup from $135.00 to $145.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the medical research company’s stock. Citigroup’s target price suggests a potential upside of 5.27% from the company’s previous […]

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price hoisted by research analysts at Citigroup from $135.00 to $145.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the medical research company’s stock. Citigroup’s price target suggests a potential upside of 5.27% from the company’s current […]